Physician profile
Chandra M Gera
NPI 1609966621
$418.06
in general payments reported to CMS, 2019-2025
9 companies · $49.54 in 2025
The $49.54 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $52.42 · 2020: $56.13 · 2021: $68.52 · 2022: $38.57 · 2023: $86.55 · 2024: $66.33 · 2025: $49.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $202.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $202.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $149.55 | 2019-2025 | |
| Harmony Biosciences LLC | $79.26 | 2020-2023 | Wakix |
| Insmed, INC. | $52.74 | 2024-2025 | Arikayce |
| Inspire Medical Systems, INC. | $37.40 | 2023 | Inspire |
| Axsome Therapeutics, INC. | $21.79 | 2023 | Sunosi |
| Takeda Pharmaceuticals U.S.A., INC. | $21.75 | 2022 | |
| 3b Medical, INC. | $20.08 | 2024 | Luna |
| Resmed Corp | $19.76 | 2020 | |
| Boston Scientific Corporation | $15.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chandra Gera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.